Biogen Presents Optimistic Outcomes from Section 2 IGNAZ Examine of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024 By Investing.com
The detailed examine outcomes confirmed interim findings, exhibiting secure kidney perform and…
